U.S. flag

An official website of the United States government

NIH: Fogarty International Center NIH: Fogarty International Center
Advancing Science for Global Health
Advancing Science for Global Health
Home > Grants > Search Current & Recent Grants > Safety, Efficacy, and Cost-Effectiveness of Rituximab for Multicentric Castleman Disease in Malawi Print

Safety, Efficacy, and Cost-Effectiveness of Rituximab for Multicentric Castleman Disease in Malawi

The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).

Funding Fogarty Program

International Research Scientist Development Award (IRSDA)

Project Information in NIH RePORTER

Safety, Efficacy, and Cost-Effectiveness of Rituximab for Multicentric Castleman Disease in Malawi

Principal Institution

University of North Carolina Chapel Hill

Principal Investigator(s) (PI)

Painschab, Matthew Scott

Project Contact Information

Email: matthew.painschab@unchealth.unc.edu

Year(s) Awarded

2019-2024

Country

Malawi

Collaborators

UNC Project Malawi
Kamuzu Central Hospital

Related World Regions / Countries

Related Global Health Research Topics